
FDA warns heart patients about antibiotic clarithromycin
(HealthDay)—The antibiotic clarithromycin (brand name: Biaxin) may increase the long-term risk of heart problems and death in patients with heart disease, according to U.S. health officials.
Feb 23, 2018
0
5